Physician Education: Bridging Clinical Research and Patient Care

Treating Hepatitis C Virus Infection in Patients With Decompensated Cirrhosis: Who, How, and Why

Thursday, September 21, 2017

1:00 PM (ET), 12:00 PM (CT), 11:00 AM (MT), 10:00 AM (PT)

Overview

Assessment of Needs

The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HCV disease as part of a nationwide continuing medical education (CME) effort for physicians.

Learning Objectives

At the conclusion of this webinar, learners will be able to:

  • Discuss the treatment of HCV in patients with decompensated cirrhosis

Registration

Who Should Attend

This webinar is designed for clinical decision makers, such as physicians, nurse practitioners and physician assistants, who have a good understanding of the basics of HCV transmission, testing, and management, and have managed HCV infection in at least 5 patients.

This activity is also relevant for registered nurses, PharmDs, and other health professionals.

Individual registration is required, even if you are viewing as a group, in order to receive CME credit or a certificate of participation.

Registration closes on Wednesday, September 20, 2017, 4:00 PM (PT).

Certificates will be available after the completion of the evaluation and claim form.

For more information or questions, please contact the registration department at registration“at”iasusa.org or 415-544-9400.

Conflicts of Interest

In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.

Continuing Education Credits

CME Credits

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credits

This activity is eligible for ANCC credit, see final CNE activity announcement for specific details.

Pharmacy Credits

Accreditation Council for Pharmacy Education logoThis activity is eligible for ACPE credit, see final CPE activity announcement for specific details.

Grant Support

This activity is part of the IAS–USA national educational effort that is funded, in part, by charitable contributions from commercial companies. Per IAS–USA policy, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speakers. Generous support for this activity has been received from the following contributors.

GOLD SUPPORTERS
Gilead Sciences, Inc
Merck

BRONZE SUPPORTER
AbbVie

Frequently Asked Questions

View our list of FAQs about attending a webinar.

Further Questions?
Please contact the registration department at registration“at”iasusa.org or 415-544-9400.

Materials

Webinar Link

You may view or share the archived recording for educational purposes, however, it is not available for CME credit.